Halozyme Therapeutics, Inc.
USD77.18
+2.22 (+2.96%)
CEO
Helen I. Torley
IPO Date
2004-03-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$75.28
Prev. Close
$74.96
Day Low
$74.47
Day High
$77.24
52W Low
$51.06
52W High
$82.22
Market Cap
$9.15B
Volume
2.08M
| 2,715 |
| $69.50 |
| 15 Jun 2026 | Snyder Mark Howard | SVP, CHIEF LEGAL OFFICER | M-Exempt | Disposed | 5,034 | $0.00 |
| 9 Jun 2026 | Snellgrove Darren | officer | Disposed | 0 | $0.00 |
| 3 Jun 2026 | Torley Helen | director, officer: PRESIDENT AND CEO | M-Exempt | Acquired | 20,000 | $12.07 |
| 3 Jun 2026 | Torley Helen | director, officer: PRESIDENT AND CEO | S-Sale | Disposed | 1,610 | $66.39 |
| 3 Jun 2026 | Torley Helen | director, officer: PRESIDENT AND CEO | S-Sale | Disposed | 12,989 | $67.41 |
| 3 Jun 2026 | Torley Helen | director, officer: PRESIDENT AND CEO | S-Sale | Disposed | 5,401 | $68.35 |
| 3 Jun 2026 | Torley Helen | director, officer: PRESIDENT AND CEO | S-Sale | Disposed | 16,600 | $66.31 |
| 3 Jun 2026 | Torley Helen | director, officer: PRESIDENT AND CEO | S-Sale | Disposed | 3,400 | $66.75 |
| Type |
|---|
| Amount |
|---|
| 8 Apr 2025 | Gilbert Cisneros | Gilbert Cisneros | Sale | $1,001 - $15,000 |
| 4 Oct 2024 | Josh Gottheimer | Josh Gottheimer | Sale | $1,001 - $15,000 |
| 13 Aug 2023 | Daniel Goldman | Daniel Goldman | Sale | $15,001 - $50,000 |
| 13 Jan 2023 | Josh Gottheimer | Josh Gottheimer | Sale (Partial) | $1,001 - $15,000 |
| 16 Sept 2022 | Josh Gottheimer | Josh Gottheimer | Sale (Partial) | $1,001 - $15,000 |
| 20 Sept 2021 | Josh Gottheimer | Josh Gottheimer | Purchase | $1,001 - $15,000 |
| 5 Nov 2020 | Gilbert Cisneros | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 5 Nov 2020 | Josh Gottheimer | Josh Gottheimer | Purchase | $1,001 - $15,000 |